Alpha-glucosidase administration: experiences in two patients with glycogen storage disease compared with animal experiments.
D000818:Animals; D001230:Aspergillus / Q000201:enzymology; D002467:Cell Nucleus / Q000378:metabolism; D004195:Disease Models, Animal; D005959:Glucosidases / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism / Q000627:therapeutic use*; D005964:Glucosyltransferases / Q000172:deficiency; D006003:Glycogen / Q000032:analysis; D006008:Glycogen Storage Disease / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D007962:Leukocytes / Q000201:enzymology; D008099:Liver / Q000032:analysis / Q000201:enzymology; D008247:Lysosomes / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D010920:Placenta / Q000201:enzymology; D051381:Rats
D006003:Glycogen; D005964:Glucosyltransferases; D005959:Glucosidases